Abstract
Background & Aims Genetic susceptibility loci for Crohn's disease (CD) are numerous, complex, and likely interact with undefined components of the environment. It has been a challenge to link the effects of particular loci to phenotypes of cells associated with pathogenesis of CD, such as Paneth cells. We investigated whether specific phenotypes of Paneth cells associated with particular genetic susceptibility loci can be used to define specific subtypes of CD. Methods We performed a retrospective analysis of 119 resection specimens collected from patients with CD at 2 separate medical centers. Paneth cell phenotypes were classified as normal or abnormal (with disordered, diminished, diffuse, or excluded granule phenotypes) based on lysozyme-positive secretory granule morphology. To uncover the molecular basis of the Paneth cell phenotypes, we developed methods to determine transcriptional profiles from whole-thickness and laser-capture microdissected, formalin-fixed, paraffin-embedded tissue sections. Results The proportion of abnormal Paneth cells was associated with the number of CD-associated NOD2 risk alleles. The cumulative number of NOD2 and ATG16L1 risk alleles had an additive effect on the proportion of abnormal Paneth cells. Unsupervised clustering analysis of demographic and Paneth cell data divided patients into 2 principal subgroups, defined by high and low proportions of abnormal Paneth cells. The disordered and diffuse abnormal Paneth cell phenotypes were associated with an altered transcriptional signature of immune system activation. We observed an inverse correlation between abnormal Paneth cells and presence of granuloma. In addition, high proportions of abnormal Paneth cells were associated with shorter time to disease recurrence after surgery. Conclusions Histologic analysis of Paneth cell phenotypes can be used to divide patients with CD into subgroups with distinct pathognomonic and clinical features.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 200-209 |
| Number of pages | 10 |
| Journal | Gastroenterology |
| Volume | 146 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2014 |
| Externally published | Yes |
Funding
Funding K.L.V. was supported by a National Institutes of Health training grant ( T32 AI007163 ). The research was funded by a Washington University Institute of Clinical and Translational Sciences Pilot Award ( CTSA308 ). The Washington University Digestive Disease Research Core Center is supported by a grant from the National Institute of Diabetes and Digestive and Kidney Disease ( P30DK052574 ). IBD Research at Cedars-Sinai is supported by US Public Health Service grant PO1DK046763 and the Cedars-Sinai F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute Research Funds. Genotyping at Cedars-Sinai Medical Center is supported in part by the National Center for Research Resources grant M01-RR00425 , UCLA/Cedars-Sinai/Harbor/Drew Clinical and Translational Science Institute grant ( UL1 TR000124-01 ), the Southern California Diabetes and Endocrinology Research grant ( DK063491 ). Project investigators are supported by The Helmsley Charitable Trust (D.P.B.M.), The European Union (D.P.B.M.), The Crohn's and Colitis Foundation of America (CCFA) (D.P.B.M.), The Feintech Family Chair in IBD (S.R.T.), The Joshua L. and Lisa Z. Greer Chair in IBD Genetics (D.P.B.M.), and grants DK043351 , DK097485 , DK092405 (R.J.X.), DK062413 , DK046763-19 , AI067068 , HS021747 (D.P.B.M.), and AI084887 (T.S.S.). T.S.S. and R.J.X. are supported by the CCFA Genetics initiative .
| Funders | Funder number |
|---|---|
| Crohn's and Colitis Foundation of America | DK092405, DK097485, AI067068, DK043351, AI084887, HS021747, DK062413, DK046763-19 |
| Clinical and Translational Sciences Institute | CTSA308 |
| Southern California Diabetes and Endocrinology Research | DK063491 |
| Leona M. and Harry B. Helmsley Charitable Trust | |
| Author National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health The Bev Hartig Huntington's Disease Foundation National Institutes of Health | T32 AI007163 |
| European Commission | |
| National Center for Research Resources | M01-RR00425 |
| Cedars-Sinai F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute | |
| National Institute of Diabetes and Digestive and Kidney Diseases | P30DK052574 |
| Penn State Clinical and Translational Science Institute | UL1 TR000124-01 |
| U.S. Public Health Service | PO1DK046763 |
Keywords
- Diagnosis
- Inflammatory Bowel Disease
- Pathogenesis
- Prognostic Factor
ASJC Scopus subject areas
- Hepatology
- Gastroenterology
Fingerprint
Dive into the research topics of 'Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of crohn's disease'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS